Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Normal Routine Spirometry Can Mask COPD/Emphysema in Symptomatic Smokers.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2021
Same author

Small airway loss in the physiologically ageing lung: a cross-sectional study in unused donor lungs.

The Lancet. Respiratory medicine·2020
Same author

Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study.

The Lancet. Respiratory medicine·2020
Same author

Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD.

Thorax·2018
Same author

Are There Differences Between the Available Treatments for Emphysema Associated with Alpha-1 Antitrypsin Deficiency?

Archivos de bronconeumologia·2018
Same author

Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT).

International journal of chronic obstructive pulmonary disease·2018
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: May 25, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

慢性閉塞性肺疾患は慢性閉塞性肺疾患である.

Marc Decramer1, Wim Janssens, Marc Miravitlles

  • 1Respiratory Division, University Hospital, University of Leuven, Leuven, Belgium. marc.decramer@uzleuven.be

Lancet (London, England)
|February 9, 2012
PubMed
まとめ
この要約は機械生成です。

慢性阻害性肺疾患 (COPD) は,進行的な気流阻害と炎症を伴うもので,感染症によって悪化することが多い. 現在の治療は,症状緩和に焦点を当て,将来の研究は,病気を修正する治療法を目指しています.

さらに関連する動画

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
05:34

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders

Published on: August 18, 2023

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

関連する実験動画

Last Updated: May 25, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
05:34

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders

Published on: August 18, 2023

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

科学分野:

  • 肺内科 肺内科 肺内科
  • 呼吸器医学とは

背景:

  • 慢性阻害性肺疾患 (COPD) は,不可逆的な空気流量制限,呼吸道炎症,および全身的な影響によって特徴づけられる進行性の呼吸器疾患です.
  • 喫煙タバコが主な原因ですが,遺伝的および環境的要因もCOPDの病原化に寄与しています.
  • 感染症によってしばしば引き起こされる悪化は,特に進行した段階で,COPDの重症性を著しく悪化させます.

研究 の 目的:

  • 慢性阻害性肺疾患 (COPD) の主要な特徴を概説する.
  • COPDの主要な原因と貢献要因について議論します.
  • 現在の治療戦略をレビューし,COPDの将来の研究方向性を提案する.

主な方法:

  • COPDに関する現在の理解の文献レビューと合成.
  • COPDにおけるエチオロギー的要因,病理生物学,および悪化を誘発する要因の分析.
  • ブロンコディラータおよび吸入用コルチコステロイドを含む現在の治療方法の評価.

主要な成果:

  • COPDは,進行的な気流阻害,炎症,心臓病や肺がんなどの併発性疾患によって定義されます.
  • バクテリア性およびウイルス性感染症は,重度の症例では最大78%を占め,COPDの悪化に大きく貢献しています.
  • Bronchodilators (β2アゴニスト,抗コレリン薬) は主要な治療法であり,潜在的に何らかの病気の修正を提供している.

結論:

  • COPDの管理は,症状を緩和し,病気の進行を潜在的に修正するために,支支支管管拡張剤に依存しています.
  • COPDの進行を大幅に変えることができる新しい治療薬の開発には,さらなる研究が不可欠です.
  • 遺伝的,環境的,感染的要因の複雑な相互作用を理解することは,COPD治療の進歩の鍵です.